COLUMBIA, Md., Aug 31, 2006 /PRNewswire-FirstCall via COMTEX/ -- Martek Biosciences Corporation (MATK) announced today the launch of a new branding initiative that includes a new brand name and logo for its flagship product, a new corporate logo and tagline, and a redesigned Web site. The new Web site will be live on September 1, 2006 at 9:00 AM (EDT). The purpose of the branding initiative is to support corporate partners in anticipation of product launches by accentuating Martek's positive public image and increasing brand awareness.
Formerly "Martek DHA," the company's flagship product, a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), will now be called life'sDHA(TM) and include the tagline "Healthy brain, eyes, heart." Based on extensive research and development conducted by Martek, the new name, logo and tagline are designed to be consumer friendly and to communicate the importance of DHA for health throughout the lifecycle.
"Martek's new product name, logo and tagline communicate the importance of DHA as a lifetime product with health benefits for people of all ages," said Steve Dubin, President and CEO of Martek. "Our new corporate look complements the life'sDHA(TM) logo in a way that is consumer friendly, while still emphasizing the science and innovation behind our products and company."
Martek Biosciences Corporation (MATK is a leader in the innovation and development of DHA Omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit the company's new Web site at www.martek.com.
Sections of this release contain forward-looking statements concerning, among other things, expectations regarding product launches, market performance and customer and consumer response. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including, but not limited to, Part II, Item 1A of the Company's Form 10-Q for the fiscal quarter ended April 30, 2006 and other filed reports on Form 10- K, Form 10-Q and Form 8-K.